Request an Invitation
CardioExchange has 4,577 members
MAGELLAN: Higher Bleeding Rates Cloud Rivaroxaban’s Effect in VTE Prevention in Acutely Ill Medical Patients
The novel anticoagulant rivaroxaban is successful in preventing venous thromboembolism (VTE) in acutely ill medical patients, but a high bleeding rate...
To continue reading, please log in to the right or
request an invitation
Member Sign In
Stay Signed In
Forgot your password?
Request an invitation
to become a CardioExchange member.
Copyrighted © 2013, Massachusetts Medical Society
The content of this site is intended for health care professionals.